These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 20485200)
1. Effect of the mutant microphthalmia-associated transcription factor found in Tietz syndrome on the in vitro development of mast cells. Shigemura T; Shiohara M; Tanaka M; Takeuchi K; Koike K J Pediatr Hematol Oncol; 2010 Aug; 32(6):442-7. PubMed ID: 20485200 [TBL] [Abstract][Full Text] [Related]
2. Functional analysis of MITF gene mutations associated with Waardenburg syndrome type 2. Zhang H; Luo H; Chen H; Mei L; He C; Jiang L; Li JD; Feng Y FEBS Lett; 2012 Nov; 586(23):4126-31. PubMed ID: 23098757 [TBL] [Abstract][Full Text] [Related]
3. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor. Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275 [TBL] [Abstract][Full Text] [Related]
4. Microphthalmia transcription factor isoforms in mast cells and the heart. Tshori S; Sonnenblick A; Yannay-Cohen N; Kay G; Nechushtan H; Razin E Mol Cell Biol; 2007 Jun; 27(11):3911-9. PubMed ID: 17438132 [TBL] [Abstract][Full Text] [Related]
5. Evidence to suggest that expression of MITF induces melanocyte differentiation and haploinsufficiency of MITF causes Waardenburg syndrome type 2A. Tachibana M Pigment Cell Res; 1997; 10(1-2):25-33. PubMed ID: 9170159 [TBL] [Abstract][Full Text] [Related]
6. Wnt signaling pathway involvement in genotypic and phenotypic variations in Waardenburg syndrome type 2 with MITF mutations. Wang XP; Liu YL; Mei LY; He CF; Niu ZJ; Sun J; Zhao YL; Feng Y; Zhang H J Hum Genet; 2018 May; 63(5):639-646. PubMed ID: 29531335 [TBL] [Abstract][Full Text] [Related]
7. [Analysis of nuclear localization and signal function of MITF protein predisposing to Warrdenburg syndrome]. Zhang H; Feng J; Chen H; Li J; Luo H; Feng Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2015 Dec; 32(6):805-9. PubMed ID: 26663053 [TBL] [Abstract][Full Text] [Related]
8. Genomic analysis of the Microphthalmia locus and identification of the MITF-J/Mitf-J isoform. Hershey CL; Fisher DE Gene; 2005 Feb; 347(1):73-82. PubMed ID: 15715979 [TBL] [Abstract][Full Text] [Related]
9. MITF-CM, a newly identified isoform of microphthalmia-associated transcription factor, is expressed in cultured mast cells. Shiohara M; Shigemura T; Suzuki T; Tanaka M; Morii E; Ohtsu H; Shibahara S; Koike K Int J Lab Hematol; 2009 Apr; 31(2):215-26. PubMed ID: 18284417 [TBL] [Abstract][Full Text] [Related]
10. The identification and functional characterization of a novel mast cell isoform of the microphthalmia-associated transcription factor. Takemoto CM; Yoon YJ; Fisher DE J Biol Chem; 2002 Aug; 277(33):30244-52. PubMed ID: 12039954 [TBL] [Abstract][Full Text] [Related]
12. MITF mediates cAMP-induced protein kinase C-beta expression in human melanocytes. Park HY; Wu C; Yonemoto L; Murphy-Smith M; Wu H; Stachur CM; Gilchrest BA Biochem J; 2006 May; 395(3):571-8. PubMed ID: 16411896 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Steingrímsson E; Moore KJ; Lamoreux ML; Ferré-D'Amaré AR; Burley SK; Zimring DC; Skow LC; Hodgkinson CA; Arnheiter H; Copeland NG Nat Genet; 1994 Nov; 8(3):256-63. PubMed ID: 7874168 [TBL] [Abstract][Full Text] [Related]
14. Interspecies difference in the regulation of melanocyte development by SOX10 and MITF. Hou L; Arnheiter H; Pavan WJ Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9081-5. PubMed ID: 16757562 [TBL] [Abstract][Full Text] [Related]
15. Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Tassabehji M; Newton VE; Read AP Nat Genet; 1994 Nov; 8(3):251-5. PubMed ID: 7874167 [TBL] [Abstract][Full Text] [Related]
16. Prognostic value of microphthalmia-associated transcription factor and tyrosinase as markers for circulating tumor cells detection in patients with melanoma. Samija I; Lukac J; Marić-Brozić J; Buljan M; Alajbeg I; Kovacević D; Situm M; Kusić Z Melanoma Res; 2010 Aug; 20(4):293-302. PubMed ID: 20357686 [TBL] [Abstract][Full Text] [Related]
17. Analyses of loss-of-function mutations of the MITF gene suggest that haploinsufficiency is a cause of Waardenburg syndrome type 2A. Nobukuni Y; Watanabe A; Takeda K; Skarka H; Tachibana M Am J Hum Genet; 1996 Jul; 59(1):76-83. PubMed ID: 8659547 [TBL] [Abstract][Full Text] [Related]
18. Ser298 of MITF, a mutation site in Waardenburg syndrome type 2, is a phosphorylation site with functional significance. Takeda K; Takemoto C; Kobayashi I; Watanabe A; Nobukuni Y; Fisher DE; Tachibana M Hum Mol Genet; 2000 Jan; 9(1):125-32. PubMed ID: 10587587 [TBL] [Abstract][Full Text] [Related]
19. [Mutation screening of MITF gene in patients with Waardenburg syndrome type 2]. Chen J; Yang SZ; Liu J; Han B; Wang GJ; Zhang X; Kang DY; Dai P; Young WY; Yuan HJ Yi Chuan; 2008 Apr; 30(4):433-8. PubMed ID: 18424413 [TBL] [Abstract][Full Text] [Related]
20. An L1 element intronic insertion in the black-eyed white (Mitf[mi-bw]) gene: the loss of a single Mitf isoform responsible for the pigmentary defect and inner ear deafness. Yajima I; Sato S; Kimura T; Yasumoto K; Shibahara S; Goding CR; Yamamoto H Hum Mol Genet; 1999 Aug; 8(8):1431-41. PubMed ID: 10400990 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]